These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 32157855

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR, Heather NL, Webster D, Albert BB, Hofman PL.
    J Clin Endocrinol Metab; 2021 Aug 18; 106(9):e3390-e3399. PubMed ID: 34058748
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
    van der Linde AAA, Schönbeck Y, van der Kamp HJ, van den Akker ELT, van Albada ME, Boelen A, Finken MJJ, Hannema SE, Hoorweg-Nijman G, Odink RJ, Schielen PCJI, Straetemans S, van Trotsenburg PS, Claahsen-van der Grinten HL, Verkerk PH.
    Arch Dis Child; 2019 Jul 18; 104(7):653-657. PubMed ID: 30712004
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D.
    J Clin Endocrinol Metab; 2004 Aug 18; 89(8):3687-93. PubMed ID: 15292289
    [Abstract] [Full Text] [Related]

  • 34. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
    Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI.
    J Steroid Biochem Mol Biol; 1999 Aug 18; 69(1-6):19-29. PubMed ID: 10418977
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
    Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M.
    Pediatr Res; 2009 Aug 18; 66(2):230-5. PubMed ID: 19390483
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P, Camilot M, Teofoli F, Tatò L.
    Horm Res; 2005 Aug 18; 63(4):180-6. PubMed ID: 15818055
    [Abstract] [Full Text] [Related]

  • 39. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S.
    Pediatrics; 1998 Apr 18; 101(4 Pt 1):583-90. PubMed ID: 9521938
    [Abstract] [Full Text] [Related]

  • 40. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].
    Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun 20; 62(6):683-96. PubMed ID: 3530828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.